Back to Authors

Dave, Hema

Mayo Clinic

From the Department of Pediatrics, Emory University School of Medicine (S.M.C., F.G.K.), and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta (S.M.C., F.G.K.) - both in Atlanta; the Department of Biostatistics, Children's Oncology

Citations 1

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma
Castellino, Sharon M. , Pei, Qinglin , Parsons, Susan K. , McCarten, Kathleen M. , Cho, Steve , Wu, Yue , Punnett, Angela , Henderson, Tara O. , Charpentier, Anne-Marie , Keller, Frank G. , Kelly, Kara M. , McCarten, Kathleen, Horton, Terzah, Dave, Hema, K Parsons, Susan , Castellino, Sharon , Hodgson, David , Horton, Terzah M. , Dave, Hema , Hoppe, Bradford S.

New England Journal of Medicine | November 2, 2022 | Volume: 387 | Issue: 18 | Pages: 1649-1660

10.1056/nejmoa2206660 Get It